NRG1 and hyperlipidemia: The finding that NRG1-induced AKT phosphorylation at Ser473 can be blunted by pre-treating cardiac myocytes with palmitate [18] suggests that over-nutrition or hyperlipidemia could lead to NRG1 resistance.